HDAC-IN-31 is a selective, potent, orally active HDAC inhibitor that acts on HDAC1 (IC50: 84.90 nM), HDAC2 (IC50: 168.0 nM), HDAC3 (IC50: 442.7 nM), HDAC8 (IC50>10000 nM). HDAC-IN-31 has good anti-tumour effects. HDAC-IN-31 has shown potential research value in diffuse large B-cell lymphoma.
Molecular Weight:
412.48
CAS Number:
[1916505-13-9]
Formula:
C25H24N4O2
Target:
Apoptosis|||HDAC|||Others
T62109
* VAT and and shipping costs not included. Errors and price changes excepted